{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:00:09Z","timestamp":1767866409973,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK072367"],"award-info":[{"award-number":["R01DK072367"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK090070"],"award-info":[{"award-number":["DK090070"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.jacl.2018.07.011","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T06:30:13Z","timestamp":1532932213000},"page":"1513-1522.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Plasma glucosylceramides and cardiovascular risk in incident hemodialysis patients"],"prefix":"10.1016","volume":"12","author":[{"given":"Mark M.","family":"Mitsnefes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Sozio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard G.","family":"Jaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Estrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"Monroy-Trujillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wujuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Setchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rulan S.","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jacl.2018.07.011_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jacl.2018.07.011_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4614-0650-1_4","article-title":"Blood sphingolipids in homeostasis and pathobiology","volume":"721","author":"Hammad","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jacl.2018.07.011_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12944-015-0053-y","article-title":"Sphingolipids in cardiovascular diseases and metabolic disorders","volume":"14","author":"Borodzicz","year":"2015","journal-title":"Lipids Health Dis"},{"issue":"2","key":"10.1016\/j.jacl.2018.07.011_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10059-010-0042-y","article-title":"Sphingolipids and the orchestration of endothelium-derived vasoactive factors: when endothelial function demands greasing","volume":"29","author":"Spijkers","year":"2010","journal-title":"Mol Cells"},{"issue":"1","key":"10.1016\/j.jacl.2018.07.011_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00004872-200101000-00009","article-title":"Impaired ceramide signalling in spontaneously hypertensive rat vascular smooth muscle: a possible mechanism for augmented cell proliferation","volume":"19","author":"Johns","year":"2001","journal-title":"J Hypertens"},{"issue":"7","key":"10.1016\/j.jacl.2018.07.011_bib6","doi-asserted-by":"crossref","first-page":"e21817","DOI":"10.1371\/journal.pone.0021817","article-title":"Hypertension is associated with marked alterations in sphingolipid biology: a potential role for ceramide","volume":"6","author":"Spijkers","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jacl.2018.07.011_bib7","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/ATVBAHA.116.305675","article-title":"Sphingolipids contribute to human atherosclerotic plaque inflammation","volume":"36","author":"Edsfeldt","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2018.07.011_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-4614-0650-1_2","article-title":"Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy","volume":"721","author":"Jiang","year":"2011","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.jacl.2018.07.011_bib9","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.atherosclerosis.2015.10.022","article-title":"Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: results of the ATHEROREMO-IVUS study","volume":"243","author":"Cheng","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2018.07.011_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.biomaterials.2015.06.001","article-title":"Improved intervention of atherosclerosis and cardiac hypertrophy through biodegradable polymer-encapsulated delivery of glycosphingolipid inhibitor","volume":"64","author":"Mishra","year":"2015","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jacl.2018.07.011_bib11","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.1210\/jc.2013-2559","article-title":"Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency","volume":"99","author":"Tarasov","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jacl.2018.07.011_bib12","doi-asserted-by":"crossref","first-page":"e85724","DOI":"10.1371\/journal.pone.0085724","article-title":"Glycerophospholipid and sphingolipid species and mortality: the Ludwigshafen risk and cardiovascular health (LURIC) study","volume":"9","author":"Sigruener","year":"2014","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.jacl.2018.07.011_bib13","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.jacl.2018.07.011_bib14","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1161\/CIRCULATIONAHA.116.024261","article-title":"Plasma ceramides, mediterranean diet, and incident cardiovascular disease in the PREDIMED trial (prevencion con dieta mediterranea)","volume":"135","author":"Wang","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2018.07.011_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12882-015-0050-4","article-title":"Rationale and design for the predictors of arrhythmic and cardiovascular risk in end stage renal disease (PACE) study","volume":"16","author":"Parekh","year":"2015","journal-title":"BMC Nephrol"},{"issue":"10","key":"10.1016\/j.jacl.2018.07.011_bib16","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1194\/jlr.M500202-JLR200","article-title":"Gaucher disease mouse models: point mutations at the acid beta-glucosidase locus combined with low-level prosaposin expression lead to disease variants","volume":"46","author":"Sun","year":"2005","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.jacl.2018.07.011_bib17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.CIR.55.4.613","article-title":"Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method","volume":"55","author":"Devereux","year":"1977","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacl.2018.07.011_bib18","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0735-1097(92)90385-Z","article-title":"Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight","volume":"20","author":"de Simone","year":"1992","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jacl.2018.07.011_bib19","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/0735-1097(94)00540-7","article-title":"Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk","volume":"25","author":"de Simone","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jacl.2018.07.011_bib20","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1111\/j.1523-1755.2004.00657.x","article-title":"Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study","volume":"65","author":"Cheung","year":"2004","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.jacl.2018.07.011_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbrc.2015.07.159","article-title":"Prevention of cardiac hypertrophy by the use of a glycosphingolipid synthesis inhibitor in ApoE-\/- mice","volume":"465","author":"Mishra","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"23","key":"10.1016\/j.jacl.2018.07.011_bib22","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1161\/CIRCULATIONAHA.113.007559","article-title":"Inhibition of glycosphingolipid synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E-\/- mice and rabbits fed a high-fat and -cholesterol diet","volume":"129","author":"Chatterjee","year":"2014","journal-title":"Circulation"},{"issue":"2-3","key":"10.1016\/j.jacl.2018.07.011_bib23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejphar.2008.02.089","article-title":"Sphingolipid signalling in the cardiovascular system: good, bad or both?","volume":"585","author":"Alewijnse","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jacl.2018.07.011_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/glycob\/7.1.57","article-title":"Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues","volume":"7","author":"Chatterjee","year":"1997","journal-title":"Glycobiology"},{"issue":"2","key":"10.1016\/j.jacl.2018.07.011_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-2275(20)30162-0","article-title":"Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice","volume":"43","author":"Garner","year":"2002","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.jacl.2018.07.011_bib26","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1006\/bbrc.2002.6356","article-title":"Modulation of THP-1 macrophage and cholesterol-loaded foam cell apolipoprotein E levels by glycosphingolipids","volume":"290","author":"Garner","year":"2002","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418303519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418303519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T11:17:59Z","timestamp":1661685479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287418303519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1933287418303519"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2018.07.011","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma glucosylceramides and cardiovascular risk in incident hemodialysis patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2018.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}